← board
USNA
distress 1/10 · well-funded / low risk$21.75-2%today-39% from 52w high
Revenue
$250M
Liquidity
$163M
Runway
—
Shares 1y
+1%
Price & events
-3.4% over 6M
CatalystRating changeDilutionFinancingdashed = today
-1.9%
1D
-4.0%
1W
+13.3%
1M
+13.0%
3M
-3.5%
6M
-38.6%
1Y
-52.7%
2Y
-78.5%
5Y
-72.1%
All
Overview
- Market Cap
- $401.57M
- Volume
- 4.26K
- 52 Week Range
- $16.90 – $35.43
- Total Shares
- 18.46M
- Float Shares
- 9.86M
- Short %
- 6.04%
- % Held by Insiders
- 40.86%
- % Held by Institutions
- 56.31%
- RVOL
- 0.04x
- Beta
- 0.73
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 1
- 2026-08-04earningsEarningsEarnings releaseyahoo
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- 2025-02-27DA DavidsonNeutral
- 2025-01-02DA DavidsonNeutral
- 2024-10-23DA DavidsonNeutral
- 2024-07-25DA DavidsonNeutral
Competitors
- none identified
Recent news
- 2026-07-22USANA Renews Partnership with Nordiq Canada - Direct Selling News
- 2026-07-22USANA Health Sciences Renews Four-Year Partnership with Nordiq Canada, - Snow Industry News
- 2026-07-20Why USANA (USNA) Stock Is Up Today - Yahoo Finance
- 2026-07-20USANA Health Sciences Renews Four-Year Partnership with Nordiq Canada, Deepening Commitment to Clean Sport and Elite Athlete Nutrition - TPI Media Group
- 2026-07-20USANA Health Sciences Renews Four-Year Partnership with Nordiq Canada, Deepening Commitment to Clean Sport and Elite Athlete Nutrition - PR Newswire
- 2026-07-19USANA stock supported by steady earnings and direct-selling reach - Ad-hoc-news.de
- 2026-07-14USANA Health Sciences sets Q2 2026 earnings release for August 4 - scanx.trade
- 2026-07-14USANA Schedules Second Quarter 2026 Earnings Release and Conference Call - Business Wire
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.